About Eurepa Tablets
Eurepa Tablet (Repaglinide) by Torrent Pharma is an anti-diabetic medication approved to lower blood sugar (glucose) levels in persons with type 2(non-insulin reliant) diabetes. Repaglinide is utilized in combination with regular diet and exercise. This oral medication assists in controlling blood sugar by motivating the pancreas to fabricate more insulin.
- Brand Name: Eurepa
- Form: 0.5mg / 1mg / 2mg
- Contents: Repaglinide
- Manufactured By: Torrent Pharma
- Other Trade Names: GlucoNorm, Prandin, Repaglid, Surepost, NovoNorm
Effective Management for Type 2 DiabetesEurepa Tablets are formulated for individuals diagnosed with Type 2 diabetes, aiming to control blood sugar levels efficiently. By helping the pancreas release insulin, these tablets regulate glucose in the bloodstream and reduce the risk of diabetes-related complications when taken as part of a healthcare routine.
Safe and Convenient Oral TherapyAdministered orally, Eurepa Tablets offer a convenient treatment option. Available in three strengths, the dosage is tailored by your physician to suit individual needs. The medicine should be stored in a cool, dry place, and taken before meals as directed, to maximize the therapeutic benefit and minimize side effects.
FAQs of Eurepa Tablets:
Q: How should Eurepa Tablets be taken for optimal blood sugar control?
A: Eurepa Tablets are best taken orally before each meal, as directed by your physician. This timing helps regulate your blood sugar levels effectively throughout the day.
Q: What is the primary benefit of using Eurepa Tablets for Type 2 diabetes patients?
A: The main benefit is improved management of blood glucose levels, which reduces the risk of long-term diabetes complications and supports better overall health when combined with diet and exercise.
Q: When should Eurepa Tablets not be used?
A: These tablets should not be used by individuals with Type 1 diabetes or those experiencing diabetic ketoacidosis, as they are unsuitable in these conditions.
Q: Where should Eurepa Tablets be stored to ensure their effectiveness?
A: Eurepa Tablets should be stored in a cool, dry place, away from sunlight and moisture, to maintain their efficacy throughout the two-year shelf life.
Q: What are the common side effects associated with Eurepa Tablets?
A: Some common side effects include hypoglycemia (low blood sugar), headache, and upper respiratory infection. Promptly inform your physician if you experience any adverse effects.
Q: How is the dosage of Eurepa Tablets determined for each patient?
A: The appropriate dosage is determined by your physician, based on your individual medical condition, blood sugar levels, and response to therapy. Never self-adjust the dose without consulting your doctor.